Telemedicine With Wearable Technologies in Patients Undergoing Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy (TEL-HEMATO Study): Prospective Noninterventional Single-Center Study

Telemedicine With Wearable Technologies in Patients Undergoing Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy (TEL-HEMATO Study): Prospective Noninterventional Single-Center Study

Authors of this article:

Lidia Hurtado¹ ;   Melinda Gonzalez Concepcion^{2, 3} ;   Aida Flix-Valle^{4, 5, 6} ;   Marina Ruiz-Romeo^{4, 6} ;   Sonia Gonzalez-Rodriguez¹ ;   Marta Peña^{1, 6} ;   Annalisa Paviglianiti^{1, 6, 7} ;   Maria Angeles Pera Jambrina¹ ;   Anna Sureda^{1, 2, 6} ;   Cristian Ochoa-Arnedo^{3, 4, 6} ;   Alberto Mussetti^{1, 6}